![[Updated] B-2 Spirit Bombers Struck Iranian Nuclear Sites](https://theaviationist.com/wp-content/uploads/2025/06/B2sGuam_2.jpg)
AstraZeneca faces new allegations over trial data for blood thinner Brilinta: BMJ
Fourteen years after AstraZeneca’s blood thinner Brilinta reached the market and now faces generic competition, the data that backed its original approvals around the world has been called into question.
Fourteen years after AstraZeneca’s blood thinner Brilinta reached the market and now faces generic competition, the data that backed its original approvals around the world has been called into question.
